Hospital de la Santa Creu i Sant Pau
Barcelona, 08041, Spain
NCT Number: NCT06063278
This a pseudo-randomized clinical trial that examines if a specific group therapy for BN is effective in improving its symptomatology, and what variables mediate such improvements. To do so a sample of 100 patients with BN will be pseudorandomized in a Group Therapy for BN or in a control waiting list group. Patients will be assessed at baseline, at the end of the group therapy and at 2 year follow up.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Barcelona, 08041, Spain
This is a controlled non randomized study that will compare a group of patients with BN that participate in the SBS group therapy with a group of BN patients who will be in wait list as a control condition.
Patients for this single center trial will be recruited from the outpatient facility of the Hospital de la Santa Creu I Sant Pau (Barcelona, Spain).
After assessed for eligibility participants will be given a set of self -report questionnaires. After the questionnaires are completed participants will be allocated to wait list condition or to the treatment arm. Time between assessment and starting the SBS group will be a month or least. Participants will be administered the same questionnaires the following month after finishing the treatment or after 3 to 4 months after the first assessment for the control condition.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
9 to 10 group sessions of 90 to 120min each
Time frame: 3 months
A self report questionarie that assesses eating disorder symptomatology. The range of scores is 0-78. Higher scores mean higher eating disorders sympthoms.
Time frame: 3 months
A self report questionarie that assesses eating disorder symptomatology. The range of scores is 0-192. Higher scores mean higher eating disorders sympthoms
Time frame: 3 months
A self report questionarie that assesses bulimia nervosa symptomatology.The range of scores is 0-30. Higher scores mean higher bulimic sympthoms
Time frame: 3 months
A self report questionarie that assesses eating disorder symptomatology. The score is ranging between 34-204 points. Higher scores point to an increased level of concern on body shape.
Time frame: 3 months
A self report questionarie that assesses bulimia nervosa symptomatology. Values range from 12 to 84. Hihger scores meaning higher therapeutic alliance.
Time frame: 3 months
A self report questionarie that assesses autistic traits. The range of scores is 0 to 50. Higher scores mean higher autistic traits.
Time frame: 3 months
A self report questionarie that assesses quality of life. The range of scores is 0-100. Higher scores mean higher quality of life.
Time frame: 3 months
A self report questionarie that assesses depressive symptoatology. The range of scores is 0-83. Higher scores mean higher depressive symptoms.
Time frame: 3 months
A self report questionarie that assesses self steem. The scale ranges from 0-30. Higher scores mean higher self-esteem. The range scores is 0-60.
Time frame: 3 months
A self report questionarie that assesses anxiety. Higher scores mean higher anxiety.
Time frame: 3 months
A self report questionarie that assesses emotion regulation difficulties. The scale ranges from 28-40. H igher scores indicate more difficulty in emotion regulation.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Other
Acronym: SBSBN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04127214
Anorexia Nervosa, Binge Eating
Argentona, Catalonia, Spain
View Trial DetailsNCT06345040
Anorexia Nervosa, Bulimia Nervosa
Hellerup, Copenhagen, Denmark
View Trial DetailsNCT06602973
Behavior, Binge-Eating Disorder
Athens, Ohio, United States
View Trial DetailsNCT06807489
Anorexia Nervosa, Binge Eating Disorder
Stockholm, Sweden
View Trial Details